Thursday, 8 July 2021, 11:13 am
The
news that Medsafe has
given approval to Johnson & Johnson’s vaccine
means the government is finally putting a backup plan in
place, after the series of close shaves it has been
experiencing of late in getting its deliveries of the Pfizer
vaccine. Around the world, Pfizer has become the preferred
choice – highly efficacious in preventing serious illness
and death, even against the Delta variant, and with (so far)
no sign of the rare but serious side effects associated with
the AstraZeneca vaccine.
Reportedly, we have two
million doses on order of J& J’s vaccine – which is